MI’s Joel Liederman on CanadaAM to talk product development
Joel Liederman, vice-president of Physical Sciences, appeared on CanadaAM April 5, 2016 to talk about how to make a product. The interview is part of CanadaAM's "What's Next" segment on…
QD Solar receives $2.55 million from Sustainable Development Technology Canada (SDTC)
TORONTO (March 17, 2016) — QD Solar, a Canadian technology company created by the University of Toronto (U of T) and MaRS Innovation, has received $2.55 million from the Sustainable…
XENiOS® invests $2.6 million in XOR-Labs Toronto
Partnership expected to revolutionize the supply of transplantable lungs, with market launch in Europe by XENiOS® expected in 2017 HEILBRONN, Germany and TORONTO, Canada — XENiOS®, a commercial-stage medical device…
BlueDot profiled in Toronto Star for anticipating Zika virus spread
BlueDot, a Canadian company that helps decision-makers prepare for and response to infectious disease outbreaks, was profiled in the Toronto Star for their work in tracking the Zika virus. The…
The Real Pinocchio Effect
TED speaker’s company is changing the technology of emotion and lie detection Consumer-facing market research studies require a group of people, a product or service for them to experience,…
ScarX Therapeutics closes $2 million Series A financing
Canadian biotech company developing ground-breaking therapeutic designed to minimize dermal scarring (fibrosis) TORONTO (February 16, 2016) — ScarX Therapeutics, a Canadian biotechnology company commercializing innovative treatments for dermal scarring…
Accel-Rx and BDC Capital make second portfolio investment in ScarX Therapeutics
MaRS Innovation portfolio company completing Phase 1 human clinical trial of drug to prevent dermal scarring VANCOUVER (February 16, 2016) — Accel-Rx Health Sciences Accelerator (Accel-Rx), a Centre of Excellence…
Ontario advancing nine medical research projects in cancer, heart disease and sleep apnea to market
Applications for next MSc PoP granting round being accepted until February 25, 2016 TORONTO (January 26, 2016) — Nine Ontario-based medical research projects built on great science with potential for…
Zucara Therapeutics Inc. developing drug to prevent hypoglycemic episodes for people with diabetes
TORONTO and VANCOUVER, CANADA (January 12, 2016) — A novel drug therapy to reduce the severity and frequency of hypoglycemic (low blood sugar) episodes in people with diabetes is being…
MLA48 Angel Investment Fund Completes Third Investment in UTEST Company
MLA48 leads ConferenceCloud pre-seed round in cooperation with UTEST TORONTO, CANADA (January 11, 2016) — MLA48, Canada’s first angel investment fund committed to providing a 48-hour turnaround on investment decisions,…